Vice President, Value, Market Access & Pricing, Europe

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team you will join other outstanding Revolutionariesin a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

We are preparing for the global commercialization of our first product addressing a significant unmet medical need with the first target indication being Pancreatic Cancer. As we build our European organization we are seeking a visionary leader to lead the European Value Market Access & Pricing team. This position will lead the development and execution of our European market access and pricing strategies tools and resources to support optimal access for pipeline addition to shaping access strategies the leader will collaborate closely with Country teams and work closely with the Global Value Access and Pricing HEOR and Medical Affairs teams.

This leader will shape and lead value and access submission and negotiation planning including optimal country launch sequence and ensure sustainable access in key European markets. Reporting to the SVP European GM this role will be a core member of the Europe Region leadership team working cross-functionally to influence long-term growth patient impact and company valuation.

Responsibilities:

Europe Value Access & Pricing Strategy

• Collaborate cross-functionally with Global teams in formulating and defining early-stage pricing and reimbursement strategies to support optimal access and reimbursement outcomes across all target regions. This includes inputting into and collaborating to help ensure a pricing architecture and launch sequence that reflects the value of our medicines.

• Build differentiated value narrativefor key European markets and contribute to the development of theGlobal Value Dossier (GVD)and payer negotiation materials.

• Work closely with members of the Disease Area & Asset teams to help shape priority clinical development plans including single agent and combinations (both with standard of care medicines other RevMed medicines and novel combinations).

• Work closely with Global teams to plan and execute country and regional payer and HTA advice as well as submissions.

• Identify and assess market access risks and opportunities in various EU countries integrating them into product strategies and reflecting them in Target Product Profiles (TPPs).

• Partner with Clinical Development HEOR and Regulatory Affairs to incorporate payer and patient relevant evidence into clinical development strategies.

• Collaborate closely with the HEOR team to ensure alignment between market access needs and health economic research plans for pipeline assets.

Launch Readiness & Market Engagement

• Work closely with the Global team to conduct European payer research andearly engagement with HTA bodies(e.g. G-BA NICE HAS AIFA AEMPS TLV ZiNL and others).

• Develop and maintain strong business relationships with key functions responsible for access with a focus on GMs Country VAP teams Clinical Commercial Regulatory Medical Affairs and HEOR stakeholders.

• Prepare and submitreimbursement and HTA dossiersin priority markets with clear alignment to clinical and economic evidence plans.

Cross-Functional and Team Leadership

• Partner with Global VAP Medical Affairs HEOR Regulatory and Clinical to align evidence generation with access and reimbursement needs.

• Build and lead ahigh-performing European Market Access team and coordinate closely with country teams to achieve reimbursement at prices that reflect the value of our medicines.

Policy Risk & External Engagement

• Monitor and address European policy risks (e.g. international reference pricing transparency laws impact of MFN etc).

• Where appropriate represent the company externally withpayers HTA bodies trade associations and policy groups helping shape access environments.

Required Skills Experience & Education:

• Bachelors degree required; advanced degree inPharmacy Health Economics Public Health Life Sciences or Businesspreferred (e.g. PharmD PhD MBA).

• Minimum15 yearsof progressive leadership in market access pricing and reimbursement within the biopharma industry.

• Demonstrated successachieving reimbursement pricing and launch success for a first-in-class or specialty therapyin European markets (especially Germany France UK etc).

• Demonstrated the ability to build and lead large multi-national teams in a global work environment needing to address and align different cultural value sets to a shared commercial strategy.

• Deep understanding of Europe payer systems and HTA processes including JCA AMNOG NICE and other EU frameworks.

• Experience designing and implementingpricing strategy including value-based pricing launch sequencing and reference price mitigation throughout Europe.

• Proven ability to workcross-functionally and influence executive leadershipin a dynamic resource-constrained early-stage company.

• Prior experience withEuropean legislation and public policies that impact regional decisions.

• Experience working for or withexternal vendors consultants and access agenciesto develop payer research modeling and dossier development.

• Strongexecutive presence with the ability to clearly articulate complex value stories to both internal and external stakeholders.

• Strong communication skills in English able to motivate and drive multi-national teams aligned with the overarching value framework of Revolution Medicines.

• Experience building or scaling European market access functionsin a pre-commercial or newly commercial biotech company or within the biopharma industry.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect process and use any personal data that you provide to us in accordance with ourCCPA additional information please contact.